WellCare price target raised to $240 from $220 at Wells Fargo. Wells Fargo analyst Peter Costa raised his price target for WellCare to $240 from $220 after the company posted a “solid” beat and raise quarter led by strength in Medicare. The analyst reiterates an Outperform rating on the shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.